$16.42
-0.82-4.76%
Last update: Nov 11, 8:53 AM
Sarepta Therapeutics Inc
SRPTNASDAQ
Sarepta Therapeutics fell 8.7% from $17.98 to $16.42, behind the S&P 500's +9.8%. Its worst day was Feb 5 (−13.7%), and its low came Jul 31 at $14.86.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Sarepta Therapeutics closed at its highest level of the year, 32.5% above where the year started.
+2.9% · S&P 500 +0.7%
Sarepta Therapeutics shares fell 13.7%, while the S&P 500 fell 1.2%.
−13.7%, the year's worst day · S&P 500 −1.2%
Story events cover the past 12 months · Times ET
EPS of $-3.58 missed the $-0.87 estimate on $442.9M revenue (est. $398.0M).
−8.0% · S&P 500 −0.6%
Sarepta Therapeutics shares rose 35.0%, while the S&P 500 rose 0.6%.
+35.0%, the year's best day · S&P 500 +0.6%
EPS of $3.16 beat the $0.91 estimate on $730.8M revenue (est. $473.6M).
−9.7% · S&P 500 −0.3%
EPS of $0.64 beat the $0.46 estimate on $401.3M revenue (est. $364.4M).
+5.3% · S&P 500 −0.2%
EPS of $0.13 missed the $0.32 estimate on $381.4M revenue (est. $349.8M).
+1.4% · S&P 500 +0.3%
Where it ended: a close of $16.42 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $-0.06, revenue est. $351.4M).
Nothing in the past 12 months.
All SRPT dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SRPT and SPY from Benzinga historical bars. Not investment advice.
